HF004
In those patients with a current diagnosis of heart failure due to left ventricular systolic dysfunction who are currently treated with an ACE-I or ARB, the percentage of patients who are additionally currently treated with a beta- blocker licensed for heart failure for heart failure
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| HF 4 | 2011 | 341 | 402 | 84.8% | |
| HF 4 | 2012 | 355 | 414 | 85.8% | |
| HF 4 | 2013 | 420 | 472 | 89.0% | |
| HF004 | 2014 | 395 | 420 | 94.0% | |
| HF004 | 2015 | 439 | 463 | 94.8% | |
| HF004 | 2016 | 456 | 474 | 96.2% | |
| HF004 | 2017 | 468 | 488 | 95.9% | |
| HF004 | 2018 | 493 | 520 | 94.8% | |
| HF004 | 2019 | 507 | 525 | 96.6% |
